Nitroimidazole adducts as markers for tissue hypoxia: mechanistic studies in aerobic normal tissues and tumour cells
1992

Nitroimidazole Adducts as Markers for Tissue Hypoxia

Sample size: 3 publication Evidence: moderate

Author Information

Author(s): M.B. Parliament, L.I. Wiebe, A.J. Franko

Primary Institution: Cross Cancer Institute, University of Alberta

Hypothesis

Can nitroimidazole markers for hypoxia bind to well-oxygenated tissues at rates comparable to hypoxic regions in tumors?

Conclusion

The study suggests that aerobic metabolism of nitroimidazoles can occur in well-oxygenated tissues, potentially affecting their use as hypoxia markers.

Supporting Evidence

  • Binding to the oesophageal mucosa was inhibited by at least 95% in the presence of 10% oxygen.
  • Dicoumarol caused only small reductions in misonidazole binding in various tissues.
  • Uptake of 125I-iodoazomycin arabinoside was directly proportional to injected dose.

Takeaway

This study looked at how certain drugs can show where tumors are low on oxygen, even in healthy tissues that have enough oxygen.

Methodology

Mice were injected with misonidazole and their tissues were analyzed for drug binding under different oxygen levels.

Potential Biases

Potential bias due to small sample size and variability in drug absorption.

Limitations

The study had a small sample size and biological variability may have affected results.

Participant Demographics

Female BALB/c mice, 10 months of age.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% confidence limits

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication